Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Portal vein thrombosis as the first sign of nephrotic syndrome

Abstract

Background A 52-year-old man presented to hospital having experienced abdominal pain, abdominal distention and oliguria for 1 week. An abdominal CT scan revealed thrombosis in the superior mesenteric vein and in the right branch and the trunk of the portal vein.

Investigations Physical examination, blood and urine analyses, color Doppler ultrasonography and abdominal CT scan.

Diagnosis Nephrotic syndrome complicated by portal vein thrombosis.

Management Treatment with batroxobin, low-molecular-weight heparin, prostaglandin E, dipyridamole and methylprednisolone.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Abdominal CT scans on admission to hospital.

References

  1. Cameron JS (1987) The nephrotic syndrome and its complications Am J Kidney Dis 10: 157–171

    Article  CAS  Google Scholar 

  2. De Luca M et al. (1991) Acute venous thrombosis of spleno-mesenteric portal axis: an unusual localization of thromboembolism in the nephrotic syndrome. Am J Nephrol 11: 260–263

    Article  CAS  Google Scholar 

  3. Ruud E et al. (2003) Successful thrombolysis by prolonged low-dose alteplase in catheter-directed infusion. Acta Paediatr 92: 973–976

    Article  CAS  Google Scholar 

  4. Arcasoy SM and Vachani A (2003) Local and systemic thrombolytic therapy for acute venous thromboembolism. Clin Chest Med 24: 73–91

    Article  Google Scholar 

  5. Perler B (2005) Thrombolytic therapies: the current state of affairs. J Endovasc Ther 12: 224–232

    Article  Google Scholar 

  6. Watanabe L et al. (2002) Crystallization of bothrombin, a fibrinogen-converting serine protease isolated from the venom of Bothrops jararaca. Acta Crystallogr D Biol Crystallogr 58: 1036–1038

    Article  CAS  Google Scholar 

  7. Pini M and Spyropoulos AC (2006) Prevention of venous thromboembolism. Semin Thromb Hemost 32: 755–766

    Article  CAS  Google Scholar 

  8. Wang W et al. (1999) A retrospective study of 3 cases of nephrotic syndrome with pulmonary thromboembolism. Zhonghua Jie He He Hu Xi Za Zhi 22: 183–185

    CAS  PubMed  Google Scholar 

  9. Krzossok S et al. (2004) Treatment of proteinuria with low-molecular-weight heparin after renal transplantation. Transpl Int 17: 468–472

    CAS  PubMed  Google Scholar 

  10. Ferretti G et al. (2006) Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants? Chest 130: 1808–1816

    Article  CAS  Google Scholar 

  11. Girolami A et al. (2002) Clinical aspects of venous thrombophilia. Pathophysiol Haemost Thromb 32: 258–262

    Article  Google Scholar 

  12. Etoh Y et al. (2002) Nephrotic syndrome with portal, splenic and renal vein thrombosis: a case report. Nephron 92: 680–684

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chenggang Xu.

Ethics declarations

Competing interests

The authors declared no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, L., Xu, C. Portal vein thrombosis as the first sign of nephrotic syndrome. Nat Rev Nephrol 4, 342–345 (2008). https://doi.org/10.1038/ncpneph0810

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0810

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing